The Trinity Challenge: Community Access to Effective Antibiotics 2025

Categories

• The Trinity Challenge on Community Access to Effective Antibiotics is particularly interested in the following two drivers:
  • Lack of stock control at the sub-national/local level in community settings.
  • Substandard and falsified oral antibiotics, which are estimated to make up 10% of antimicrobials used by humans in LMICs and 6.5% of veterinary medicines.

Prize Information

• A prize fund of up to £1,000,000 will be awarded, with an aim to award a grand prize of £500,000 in each category of the Challenge (Stock Control and Substandard and Falsified Antibiotics).
• Other prizes may be made at the discretion of the Judges e.g. runner-up prizes or honourable mentions for solutions outstandingly meeting some criteria.
• The exact amount of the prize for each winner will depend on the solution’s needs for development, deployment, and scaling over the next two years.

Eligibility Criteria

• Applicants from all over the world are encouraged to apply. This Challenge particularly encourages solutions from teams based in low- and middle-income countries (LMICs) and multi-disciplinary teams. Previous Trinity Challenge applicants are able to apply.
• Solutions must:
  • Focus on interventions in LMICs
    • A minimum of 60% prize funding must be spent in LMICs
    • Utilise or generate community-level data in LMICs i.e outside of hospital/formal healthcare settings and industry
    • Demonstrate the potential to scale to positively impact the lives of LMIC populations
      Focus on stock control and/or substandard and falsified oral antibiotics
  • If focus is human health, it should be on oral antibiotics in the community setting.
    • If focus is animal health, it should be on antibiotics in feed or water for food production animals, or oral antibiotics for companion animals.
    • We welcome existing solutions focused on community-level health, agricultural, or other relevant data and analytics that can be adapted as long as there is a justification for how it could be applied to stock control and/or substandard and falsified antibiotics.

For more information, visit Solve.